Literature DB >> 8430064

Mean residence time of oral drugs undergoing first-pass and linear reversible metabolism.

H Cheng1, W J Jusko.   

Abstract

Equations for the mean residence times in the body (MRT) and AUMC/AUC of a drug and its metabolite have been derived for an oral drug undergoing first-pass and linear reversible metabolism. The mean residence times of the drug or interconversion metabolite in the body after oral drug are described by equations which include the mean absorption time (MAT), the mean residence times of the drug or metabolite in the body after intravenous administration of the drug, the fractions of the dose entering the systemic circulation as the parent drug and metabolite, and the systemically available fractions of the drug (Fpp) or metabolite (Fpm). Similarly, the AUMC/AUC of the drug and metabolite after oral drug can be related to the MAT, ratios of the fraction of the dose entering the systemic circulation to the systemically available fraction, the first-time fractional conversion of each compound, and AUMC/AUC ratios after separate intravenous administration of each compound. The Fpp and Fpm values, in turn, are related to the first-pass availabilities of both drug and metabolite and the first-time fractional conversion fractions. The application of these equations to a dual reversible two-compartment model is illustrated by computer simulations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8430064     DOI: 10.1023/a:1018904509178

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  Effects of first-pass metabolism on metabolite mean residence time determination after oral administration of parent drug.

Authors:  K K Chan; M Gibaldi
Journal:  Pharm Res       Date:  1990-01       Impact factor: 4.200

2.  Mean interconversion times and distribution rate parameters for drugs undergoing reversible metabolism.

Authors:  H Y Cheng; W J Jusko
Journal:  Pharm Res       Date:  1990-10       Impact factor: 4.200

3.  Theory of the mean absorption time, an adjunct to conventional bioavailability studies.

Authors:  D J Cutler
Journal:  J Pharm Pharmacol       Date:  1978-08       Impact factor: 3.765

4.  Constant-rate intravenous infusion methods for estimating steady-state volumes of distribution and mean residence times in the body for drugs undergoing reversible metabolism.

Authors:  H Cheng; W J Jusko
Journal:  Pharm Res       Date:  1990-06       Impact factor: 4.200

5.  Estimation of the rates of available fraction for some 4-substituted acetophenone derivatives in the rat: reversible drug-metabolite pharmacokinetics.

Authors:  S Nagamine; T Otawa; H Nakae; S Asada
Journal:  Chem Pharm Bull (Tokyo)       Date:  1988-11       Impact factor: 1.645

6.  General method for assessing bioavailability of drugs undergoing reversible metabolism in a linear system.

Authors:  S S Hwang; W F Bayne
Journal:  J Pharm Sci       Date:  1986-08       Impact factor: 3.534

7.  Mean residence time for drugs subject to reversible metabolism.

Authors:  L Aarons
Journal:  J Pharm Pharmacol       Date:  1987-07       Impact factor: 3.765

8.  LAGRAN program for area and moments in pharmacokinetic analysis.

Authors:  M L Rocci; W J Jusko
Journal:  Comput Programs Biomed       Date:  1983-06

9.  A liner mode of reversible metabolism and its application to bioavailability assessment.

Authors:  S Hwang; K C Kwan; K S Albert
Journal:  J Pharmacokinet Biopharm       Date:  1981-12

10.  Reversible metabolism and pharmacokinetics: application to prednisone-prednisolone.

Authors:  J G Wagner; A R DiSanto; W R Gillespie; K S Albert
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1981-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.